Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
BVS
|
Guy P Nohra
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,700 Added 18.75% |
-
|
Apr 01
2022 |
BVS
|
Philip G. Cowdy
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 2,700 Added 18.75% |
-
|
Apr 01
2022 |
BVS
|
John Nosenzo
Fmr. Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 106,485 Added 41.53% |
-
|
Apr 01
2022 |
BVS
|
Anthony D'Adamio
SVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct | 37,476 Added 40.03% |
-
|
Apr 01
2022 |
BVS
|
William A Hawkins
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 40,573 Added 30.52% |
-
|
Apr 01
2022 |
MPB
|
David E Sparks
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,133 Added 38.16% |
-
|
Apr 01
2022 |
MPB
|
Rory G Ritrievi
President and CEO |
BUY
Grant, award, or other acquisition
|
Direct | 8,494 Added 28.06% |
-
|
Apr 01
2022 |
MPB
|
Gregory M Kerwin
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,133 Added 38.16% |
-
|
Apr 01
2022 |
MPB
|
Donald F. Kiefer
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,133 Added 38.16% |
-
|
Apr 01
2022 |
MPB
|
Theodore W Mowery
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,133 Added 38.16% |
-
|
Apr 01
2022 |
MPB
|
Noble C Quandel Jr
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,133 Added 38.16% |
-
|
Apr 01
2022 |
MPB
|
Robert A Abel
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,133 Added 38.16% |
-
|
Apr 01
2022 |
MPB
|
John E Noone
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,133 Added 38.16% |
-
|
Apr 01
2022 |
MPB
|
Brian Arden Hudson Sr.
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,133 Added 38.16% |
-
|
Apr 01
2022 |
MPB
|
Kimberly J Brumbaugh
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,133 Added 38.16% |
-
|
Apr 01
2022 |
MPB
|
Matthew G De Soto
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,133 Added 38.16% |
-
|
Apr 01
2022 |
MPB
|
Maureen M. Gathagan
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,133 Added 50.0% |
-
|
Apr 01
2022 |
MPB
|
Howard R. Greenawalt
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,133 Added 50.0% |
-
|
Apr 01
2022 |
MPB
|
Robert C Grubic
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,133 Added 38.16% |
-
|
Apr 01
2022 |
MPB
|
Justin T. Webb
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 1,511 Added 31.16% |
-
|
Apr 01
2022 |
MPB
|
William A Specht Iii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,133 Added 38.16% |
-
|
Apr 01
2022 |
MPB
|
Scott W Micklewright
Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct | 1,511 Added 31.16% |
-
|
Apr 01
2022 |
MPB
|
Joseph L Paese
Dir. Trust, Wealth Mgmt |
BUY
Grant, award, or other acquisition
|
Direct | 680 Added 26.05% |
-
|
Apr 01
2022 |
MPB
|
Joan E Dickinson
Chief Retail Officer |
BUY
Grant, award, or other acquisition
|
Direct | 680 Added 28.81% |
-
|
Apr 01
2022 |
MPB
|
Margaret E Steinour
FSVP/Chief Admin Officer |
BUY
Grant, award, or other acquisition
|
Direct | 500 Added 23.82% |
-
|
Apr 01
2022 |
SENS
|
Stephen P De Falco |
BUY
Grant, award, or other acquisition
|
Direct | 12,886 Added 1.06% |
$24,999
$1.94 p/Share
|
Apr 01
2022 |
SENS
|
Edward Fiorentino |
BUY
Grant, award, or other acquisition
|
Direct | 7,280 Added 1.65% |
$14,123
$1.94 p/Share
|
Apr 01
2022 |
SENS
|
Edelman Steven |
BUY
Grant, award, or other acquisition
|
Direct | 4,977 Added 1.25% |
$9,655
$1.94 p/Share
|
Apr 01
2022 |
SENS
|
Douglas S Prince |
BUY
Grant, award, or other acquisition
|
Direct | 4,832 Added 1.55% |
$9,374
$1.94 p/Share
|
Apr 01
2022 |
SENS
|
Sharon Larkin |
BUY
Grant, award, or other acquisition
|
Direct | 3,745 Added 4.7% |
$7,265
$1.94 p/Share
|
Apr 01
2022 |
CARA
|
Frederique Ph.D. Menzaghi
CHIEF SCIENTIFIC OFF,SVP-R&D |
SELL
Open market or private sale
|
Direct | 1,784 Reduced 1.04% |
$21,247
$11.91 p/Share
|
Apr 01
2022 |
CARA
|
Joana Goncalves
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,642 Reduced 2.15% |
$19,556
$11.91 p/Share
|
Apr 01
2022 |
CARA
|
Scott Terrillion
SEC'Y; CHIEF COMPLIANCE & G.C. |
SELL
Open market or private sale
|
Direct | 1,642 Reduced 1.58% |
$19,556
$11.91 p/Share
|
Apr 01
2022 |
VRAY
|
Susan C Schnabel
Director |
BUY
Grant, award, or other acquisition
|
Direct | 52,944 Added 37.49% |
-
|
Apr 01
2022 |
THR
|
John U Clarke
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,461 Added 6.32% |
$23,741
$16.25 p/Share
|
Apr 01
2022 |
THR
|
Linda Dalgetty
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,461 Added 6.92% |
$23,741
$16.25 p/Share
|
Apr 01
2022 |
THR
|
Roger L Fix
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,461 Added 7.17% |
$23,741
$16.25 p/Share
|
Apr 01
2022 |
THR
|
Marcus J George
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,461 Added 3.73% |
$23,741
$16.25 p/Share
|
Apr 01
2022 |
THR
|
Kevin J Mcginty
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,461 Added 3.56% |
$23,741
$16.25 p/Share
|
Apr 01
2022 |
THR
|
John T Nesser Iii
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,461 Added 3.3% |
$23,741
$16.25 p/Share
|
Apr 01
2022 |
OFIX
|
Kimberley A. Elting
President, Global Orthopedics |
SELL
Payment of exercise price or tax liability
|
Direct | 2,385 Reduced 3.54% |
$78,800
$33.04 p/Share
|
Apr 01
2022 |
OFIX
|
Jon Carl Serbousek
Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct | 5,940 Reduced 3.05% |
$196,258
$33.04 p/Share
|
Apr 01
2022 |
OFIX
|
Rice Doug
CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,569 Reduced 2.69% |
$84,880
$33.04 p/Share
|
Apr 01
2022 |
OFIX
|
Kevin J. Kenny
President of Global Spine |
SELL
Payment of exercise price or tax liability
|
Direct | 1,955 Reduced 3.45% |
$64,593
$33.04 p/Share
|
Apr 01
2022 |
OFIX
|
Paul Gonsalves
President, Global Orthopedics |
SELL
Payment of exercise price or tax liability
|
Direct | 687 Reduced 2.6% |
$22,698
$33.04 p/Share
|
Apr 01
2022 |
RLMD
|
Charles J Casamento
Director |
SELL
Open market or private sale
|
Direct | 19,800 Reduced 100.0% |
$574,200
$29.0 p/Share
|
Apr 01
2022 |
RLMD
|
Charles J Casamento
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 19,800 Added 50.0% |
$64,152
$3.24 p/Share
|
Apr 01
2022 |
CCO
|
Brian D. Coleman
Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 125,146 Reduced 14.06% |
$435,508
$3.48 p/Share
|
Apr 01
2022 |
CCO
|
Brian D. Coleman
Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 161,812 Added 15.38% |
-
|
Apr 01
2022 |
CCO
|
Scott Wells
Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 198,693 Reduced 11.52% |
$691,452
$3.48 p/Share
|
Apr 01
2022 |